It has become clear that ultraviolet A (UVA) radiation from the solar spectrum is a major environmental challenge to the skin. This necessitates developing novel mechanism-based agents capable of ameliorating UVAinduced effects in the skin. We recently described a novel antioxidant, 3-O-Caffeoyl-1-methylquinic acid (MCGA3) from leaves of bamboo. Here, we investigated the photochemopreventive effects of MCGA3 against UVAmediated apoptosis in immortalized HaCaT keratinocytes. Pretreatment of MCGA3 rendered cells more sensitive to subsequent UVA irradiation-induced apoptosis as well as completely reversed UVA-induced sustained phosphorylation of extracellular signal-regulated kinase 1/2 and protein kinase Ca, downregulation of p21, and reactive oxygen species generation. Interestingly, MCGA3 itself effectively induced p21 protein and mRNA levels. Silencing of p21 by RNA interference revealed a pivotal role of p21 in generating G 1 -S arrest and in enhancing UVA-mediated apoptosis. Transcriptional activation of p21 by MCGA3 was mediated through the proximal region of multiple Sp1 sites regardless of p53-binding site in p21 promoter, and this effect was augmented by desferroioxamine, an iron chelating agent. Additional studies suggested that iron chelation-driven hypoxia by MCGA3 may function in activation of p21. MCGA3 could be a useful agent to prevent photocarcinogenesis via apoptotic elimination of p53 mutant and DNA-repair defective cells caused by UVA radiation.
Introduction
Ultraviolet light A (UVA; 315-400 nm) has been considered far less carcinogenic based on limited direct damage to DNA as compared to UVB (280-315 nm) (de Gruijl, 2002) . However, UVA constituting about 95% of ultraviolet irradiation in natural sunlight represents a major environmental challenge to the skin and is clearly associated with human skin cancer (Agar et al., 2004; Bachelor and Bowden, 2004) . Cells damaged by UVA normally undergo apoptosis, but failure in this process plays an important role in tumor development. Indeed, cell survival can be promoted by active suppression of apoptosis via survival signals, thus allowing potential malignant transformation (Bachelor and Bowden, 2004; He et al., 2006) . Therefore, apoptotic elimination of UV-damaged epidermal keratinocytes is an efficient and ideal protective mechanism in preventing development of skin cancer (Reagan-Shaw et al., 2006) .
Cyclin-dependent kinase inhibitor, p21 WAF1/Cip1 (p21), an important negative regulator of cell cycle and cell proliferation, has been suggested as a preceding indicator of apoptosis and a tumor suppressor in skin and many other cancer cells. The regulation of p21 occurs primarily at the transcriptional and post-transcriptional levels (Gartel and Radhakrishnan, 2005) . p21 was originally identified as a downstream mediator of p53-induced growth arrest, but now it is well established that the p21 expression is controlled by diverse mechanisms in both p53-dependent or -independent manner (Gartel and Radhakrishnan, 2005) . In addition to p53-binding to the distal region of p21 promoter, studies have shown that Sp1 family of transcription factors (Sp1 and Sp3) binds to six GC-rich motifs present in the proximal promoter of the human p21 gene (Koutsodontis et al., 2002) . Hypoxia-inducible factor (HIF)-1a and c-Myc, transcriptional regulators of Sp1, are known to activate or inhibit the transactivation of p21. c-Myc binds to Sp1-binding site in proximal promoter region of p21 and represses transcription of p21, thereby abolishing p21-mediated cell cycle checkpoint (Gartel et al., 2001, Mukherjee and Conrad, 2005) . On the contrary, HIF-1a stabilized by iron chelation functionally counteracts and displaces c-Myc from the p21 promoter, leading to transcriptional activation of p21 and subsequent growth arrest (Koshiji et al., 2004) .
Mutation of p53 has been recognized as one of the major events in carcinogenesis, in more than 50% of human cancers including skin cancer (Wanner et al., 2002) , whereas the mutation of p21 in human cancers is rare (Gartel and Radhakrishnan, 2005) . Therefore, agents that could activate p21 through a p53-independent mechanism like Sp1-mediated transcriptional activation might contribute to chemotherapy or prevention of cancer as molecular-targeted drug candidate (Patel et al., 2002) . 3-O-Caffeoyl-1-methylquinic acid (MCGA3), which belongs to a methyl chlologenic acid ester, was first isolated and identified by our group as a novel antioxidant from leaves of bamboo plant, Phyllostachys edulis (Kweon et al., 2004) . MCGA3 possesses strong antioxidant effects and protects vascular endothelial cells against reactive oxygen species (ROS)-induced cellular damage via induction of Nrf2-mediated phase II detoxifying enzymes (Kweon et al., 2006) . In this study, we investigated the photochemopreventive potential of MCGA3 on UVA-induced apoptosis in HaCaT keratinocytes that harbor UVinduced mutations on both alleles of the p53 gene (Wanner et al., 2002) . The present study provides evidence that p21 upregulation is required for MCGA3-induced cell cycle arrest as well as apoptosis in UVA-exposed HaCaT cells. Possible mechanism of Sp1-dependent p21 transcriptional activation by MCGA3 was further investigated by focusing on its potential role in iron chelation and regulation of HIF-1a and c-Myc.
Results

Pretreatment of MCGA3 enhances UVA-mediated apoptosis
HaCaT cells were either exposed to UVA or UVB and with or without pretreatment of MCGA3. At 24 h post-UV exposure, MTT assay was performed to assess the effect of these treatments on cell viability. We found that cells exposed to UVB (15-16 mJ/cm 2 ) but not to UVA (5-30 J/cm 2 ) resulted in significant dose-dependent decrease in cell viability (Figure 1a and 1b) . When HaCaT cells were pretreated with MCGA3 (2.5-50 mM) for 24 h before UV exposure, the loss of cell viability by UV exposure was significantly enhanced, and this effect was more pronounced after UVA exposure than UVB exposure (Figure 1a and b). Consistent with this observation, morphological examination by phase contrast microscopy and diphenyltetrazolium bromoide staining also show that cells preincubated with MCGA3 were more sensitive to subsequent exposure of UVA in comparison with cells exposed to UVA alone ( Figure 1c ). Under identical conditions, normal human epidermal keratinocytes (NHEK) were more resistant to UVA (5-30 J/cm 2 ; 24 h)-mediated decrease in cell viability than HaCaT cells. The effects of MCGA3 treatment to NHEK on decrease in cell viability in response to UVA were only marginal (data not shown). To evaluate whether this increased loss of cell viability after UVA exposure in cells pretreated with MCGA3 is mediated through apoptotic cell death, we stained these cells with Annexin-V-Fluorescein. As shown in Figure 1d , it is evident that cells pretreated with the indicated amount of MCGA3 followed by UVA exposure show dose-dependent increase in apoptotic cell death. However, cells treated with MCGA3 (30 mM) alone did not show any significant apoptotic cell death.
We further found that MCGA3 pretreatment significantly enhances UVA-mediated apoptosis as observed by DNA fragmentation (Figure 2a ) and poly(ADP-ribose) polymerase (PARP) cleavage (Figure 2b ), which are representative indicators of cellular apoptosis. Similar to the cell viability data, MCGA3 treatment itself did not induce apoptotic death. We found that pretreatment of cells with MCGA3 (10-30 mM) followed by UVA (30 mJ/cm 2 ) exposure resulted in a dose-dependent decrease in the expression of procaspase-3 and procaspase-8, indicating caspasemediated apoptosis (Figure 2c ). Pretreatment of MCGA3 was also found to enhance UVA-mediated decrease in Bcl-xL and increase in Bak protein levels, resulting in a shift in Bak/Bcl-xL ratio that favor apoptosis (Figure 2d ).
MCGA3 inhibits UVA-initiated survival signals
To determine the early effect of UVA exposure on protein kinase C alpha (PKCa), mitogen-activated protein kinases (MAPKs) and phosphotidylinositol-3-kinase (PI3K)/AKT, HaCaT cells were irradiated with 30 J/cm 2 , and time response studies were performed. Immunoblots showed a marked phosphorylation of extracellular signal-regulated kinase (ERK)1/2, JNK1/2 and p38 within 15-30 min after UVA exposure (Figure 3a) . Interestingly, the phosphorylation of ERK1/2 and PKCa was sustained up to 6 h after UVA exposure (Figure 3a ), but activation of other kinases were found to be emaciated within 2 h after UVA exposure.
We found that MCGA3 pretreatment resulted in inhibition of the sustained ERK1/2 and PKCa activation by UVA in a dose-dependent manner (Figure 3b ), which may serve as a mechanism for the enhanced apoptosis by MCGA3. As high dose of UVA in the absence of photosensitizing chemicals induces apoptosis by generation of ROS and ROS-mediated mechanism in skin cells (Valencia and Kochevar, 2006) , we tested a hypothesis that MCGA3 could enhance apoptosis through accelerating ROS generation by UVA. For measuring intracellular level and localization of ROS, we employed confocal fluorescence microscopy with a fluorescence probe, 2 0 , 7 0 -dichlorofluorescein diacetate (DCFH-DA), which converts into highly fluorescent dichlorofluorescein (DCF) in the presence of intracellular ROS (Martin et al., 1998; Kweon et al, 2004) . Cells were also treated with the mitochondria-specific probe Mito Tracker for 15 min before imaging. As shown in (Wang et al., 2000) . In contrast, MCGA3 treatment alone did not cause ROS production but rather decreased basal level of ROS ( Figure 3c , upper panel) as well as significantly scavenged the ROS triggered by UVA irradiation (Figure 3c , lower panel). These results suggest that enhancement of UVA-mediated apoptosis by MCGA3 may be through ROS attenuation rather than by increased production of ROS.
MCGA3 upregulates p21 as well as overcomes UVA-mediated early decrease of p21 Hypoxia not only induces angiogenesis and promotes cell growth and survival in cancer cells but also leads to growth arrest and apoptosis (Carmeliet et al., 1998; Goda et al., 2003; Greijer and van der Wall, 2004) . Recently, hypoxia-mediated cell cycle arrest and induction of apoptosis has been shown to be regulated by p21 activation (Bossenmeyer-Pourie et al., 2002) . As MCGA3 may lead to hypoxia by lowing intracellular ROS ( Figure 3c ) and by chelating free iron (Kweon et al., 2001 (Kweon et al., , 2004 , we first investigated the effect of MCGA3 on expression of p21. When HaCaT cells were treated with MCGA3, protein expression of p21 but not of p27 was significantly increased in a time-dependent manner, which was evident as early as 2 h of treatment and peaked at 12-18 h, but remained elevated upto 24 h ( Figure 4a ). Consistent with this result, maximum enhancement effect in loss of cell viability by UVA irradiation was observed in cells preincubated for 12-18 h with MCGA3 ( Figure 4b ).
Interestingly, we found that early response of UVA (15-60 min post-irradiation) exposure leads to downregulation of p21 ( Figure 4c Figure 4d ). These data suggest that enhancement of UVA-mediated apoptosis by MCGA3 may be due to hypoxia-dependent p21 upregulation.
Effect of silencing of p21 on cell cycle arrest and apoptosis Cells were transfected with 25 nM of p21-siRNA and subsequently incubated with MCGA3 and harvested at 1, 6, 12 and 24 h. As expected, increased p21 expression MCGA3 activates p21 and enhances UVA-mediated apoptosis M-H Kweon et al was observed in cells treated with MCGA3 alone. However, this elevated expression of p21 was suppressed by p21-siRNA even at 6 h of transfection ( Figure 5a ). Cells treated with MCGA3 alone or MCGA3 followed by UVA exposure in the presence or absence of p21-siRNA were then subjected to immunocytochemistry for Ki67, a cell proliferation marker located in nucleus (Chung et al., 2003) . In control cells, a strong nuclear staining of Ki67 protein was observed and Ki67 was not significantly affected by p21 silencing (Figure 5b , upper panel). Treatment of MCGA3 alone or MCGA3 treatment followed by UVA irradiation (1 h) resulted in a markedly decreased expression of Ki67 that was completely reversed by p21 silencing (Figure 5b ), indicating antiproliferative potential of MCGA3 via p21 upregulation. We further found that treatment of MCGA3 alone or treatment followed by UVA exposure (1 h) resulted in significant increase in the number of cells in G 1 phase (approximately 68 and 65%) and decrease in number of cells in S phase (approximately 18 and 17%) as compared to control cells (G 1 : 41. 9% and S: 41.8%) (Figure 5c ). This G 1 -S arrest effect by MCGA3 alone or subsequent exposure of UVA (1 h) was partially abrogated by p21 silencing where approximately 50 and 51% of cells were in G 1 phase; 30 and 28% of cells were in S phase (Figure 5c ). This data suggest that p21 activation contributes to induction of cell cycle arrest at G 1 -S phase by MCGA3.
As shown in Figure 6a , decreased expression of cyclin D1 and procaspase 3, and PARP cleavage by MCGA3 preincubation followed by UVA (24 h) exposure, were reversed by p21 silencing (Figure 6a ), indicating antiproliferative and proapoptotic function of MCGA3 through p21 upregulation. The major role of p21 in the enhancement effect of UVA-mediated apoptosis by MCGA3 was further clearly demonstrated by DNA fragmentation assay (Figure 6b ) and TUNEL assay (Figure 6c and d) .
The proximal Sp1-binding sites, but not the p53-binding sites of the p21 promoter mediate MCGA3-dependent transcriptional upregulation of p21 Interestingly, we found that MCGA3 treatment resulted in elevated expression of p53 and p21. However, Bax and growth arrest and DNA damage (GADD), known p53 target genes, did not show any significant changes when compared to untreated cells ( Figure 7a ). As HaCaT cells are known to express functionally defective p53 (Kallassy et al., 1998; Wanner et al., 2002) , it was likely that the increased level of p53 by MCGA3 has no effect on the induction of p21. We next found that treatment of MCGA3 increased the mRNA expression of p21 in a time-dependent fashion (Figure 7b ). To investigate the MGCA3-mediated transcriptional activation of the p21, we transiently transfected HaCaT cells with several human p21 promoter-driven luciferase reporter plasmids, À2325/ þ 8 hp 21-luc (wild-type fulllength p21 promoter), À215/ þ 8 hp 21-luc (minimal promoter region that lacks p53-binding site and contains six Sp1-binding sites), À2325/ þ 8 D143/ þ 8 hp 21-luc (promoter that lacks six consensus Sp1-binding sites) (Koutsodontis et al., 2002; Gartel and Radhakrishnan, 2005) .
As shown in Figure 7c , MCGA3 significantly enhanced activation of the full-length (À2325/ þ 8) p21 promoter by 9.5-fold when compared to control. Surprisingly, MCGA3 treatment resulted in 11.5-fold more activity in promoter (À215/ þ 8) that lacks the p53-binding site, but deletion of the six putative Sp1-binding sites (D143/ þ 8) resulted in complete loss of promoter activity (Figure 7c ). We then found that MCGA3 activates (À215/ þ 8 hp p21-luc) promoter in a time-dependent manner (Figure 7d ), which is in consistent with induction of p21 mRNA (Figure 7b) . Thus, these data suggest that, activation of p21 promoter in MCGA3-treated cells is mediated through Sp1-binding region but not through p53-binding region.
Iron is associated with Sp1-dependent transcriptional activation of p21 by MCGA3 In addition to the ability of ROS scavenging, MCGA3 possess iron-chelating potential through its o-dihydroxyl and its unsaturated carbonyl with neighboring hydroxyl groups (Kweon et al., 2001) . Treatment with iron MCGA3 activates p21 and enhances UVA-mediated apoptosis M-H Kweon et al chelators mimics oxygen deprivation and hypoxic induction of HIF-1a, which activates transcription of transferring receptor 1 (TfR1) (Bianchi et al., 1999) . To confirm iron chelation by MCGA3, we determined changes in the expression pattern of proteins, ferritin and TfR1, that are regulated by intracellular iron content (Jiao et al., 2006) , in cells treated with MCGA3. As shown in Figure 8a , the level of ferritin was found to be decreased by MCGA3 treatment, which is evident at 8 h after treatment, whereas TfR1 protein level was more rapidly elevated by MCGA3 treatment, which is evident at 2 h and gradually increased in a timedependent manner. Studies have shown cross-link between intracellular iron deprivation-induced hypoxia and p53-independent p21 upregulation (Abeysinghe et al., 2001; Baby et al., 2003) . Similarly, our results also shows, MCGA3 treatment induces p21 and TfR1 protein levels in timedepended manner (Figures 4a and 8a) . Thus, we hypothesized that iron chelation by MCGA3 may play a role in Sp1-mediated p21 transcriptional activation. To assess this possibility, we co-treated cells with MCGA3 and a potent iron chelator, deferoxamine (DFO), or an iron supplementary FeCl 3 along with N-acetylcysteine (NAC), an ROS scavenging compound without iron chelation potential. We observed FeCl 3 completely reversed MCGA3-mediated induction of p21 mRNA and protein expression, whereas DFO augmented p21 induction by MCGA3 (Figure 8b ). On the other hand, NAC did not alter p21 induction by MCGA3. To investigate whether these effects occur at an Sp1-dependent activation of p21 promoter, we transiently transfected cells with the (À215/ þ 8) or (À2325/ þ 8 D143/ þ 8) constructs and subsequently co-treated with MCGA3 or FeCl 3 or DFO or NAC, in a same method as described above. Similar results were obtained in (À215/ þ 8); p21-promoter activation in all samples without any activation of (À2325/ þ 8 D143/ þ 8) that lacks Sp1-binding site. These results confirmed that Sp1-mediated p21 transcriptional activation by 
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MCGA3 is closely associated with its potential of iron chelation.
Are HIF-1a and c-Myc involved in p21 induction by MCGA3? Iron depletion or hypoxia stabilizes the HIF-1a protein by inhibition of the hydroxylation that subsequently leads to increased p53 levels (Hammond and Giaccia, 2005) . In addition, HIF-1 is known to regulate Sp1-dependent p21 transcription by functionally counteracting c-Myc, a known repressor of p21 (Gartel and Radhakrishnan, 2005) . Because MCGA3 treatment increases expression of p53 (Figure 7a ), we hypothesized that iron chelating and ROS scavenging potentials of MCGA3 may stabilize HIF-1a and affect c-Myc expression. As shown in Figure 9a and b, treatment of MCGA3 and DFO both resulted in accumulation of HIF-1a along with strong induction of p21 and downregulation of c-Myc, which is inversely associated with p21 expression (Figure 9a and b) , strongly indicating the involvement of iron chelation and hypoxia in stabilization of HIF-1a.
To ascertain the involvement of HIF-1a and c-Myc in activation of p21 by MCGA3, cells were transiently transfected with p21 or c-Myc-siRNA. Surprisingly, silencing the p21 (Figure 9c ) resulted in dose-dependent increase in c-Myc expression and unaltered expression of HIF-1a. However, silencing the c-Myc did not alter the expression of either p21 or HIF-1a (Figure 9d ), indicating that HIF-1a is a key modulator of c-Myc and p21 regulation. In addition, silencing of c-Myc produced no significant effects in Sp1-dependent p21 promoter activity (data not shown). These results suggest that HIF-1a rather than c-Myc may be involved in MCGA3-mediated p21 activation.
Discussion
Although it has proven difficult to show direct effect of UVA as a carcinogen in human skin, recent in vitro study shows that chronic exposures to environmentally relevant doses of UVA induces malignant transformation of HaCaT cells and shown to be associated with MCGA3 activates p21 and enhances UVA-mediated apoptosis M-H Kweon et al acquired apoptotic resistance (Bachelor and Bowden, 2004; He et al., 2006) . In this study, for the first time, we show the photoprotective effect of MCGA3 with documented proapoptotic and antiproliferative effects in UVA-irradiated HaCaT cells. MCGA3 was found to sensitize the UVA-exposed HaCaT cells to undergo apoptosis as an effective defense mechanism. In consistent with previous observation (He et al., 2004) , prosurvival, sustained activation of ERK1/2 and PKCa was observed in UVA-irradiated HaCaT cells (Figure 3a) . Interestingly, MCGA3 significantly inhibits the UVA-induced phosphorylation of ERK and PKCa (Figure 3b ). This effect is probably due to scavenging potential of MCGA3 to remove/reduce UVA-generated ROS (Figure 3c ) as phosphorylation of these two kinases is known to be typical cellular response against ROS stress (Song et al., 2005) . Thus, this abrogation of prosurvival signals may also be important in MCGA3-mediated apoptotic enhancement and p21 activation.
We then focused on rapid and prominent induction of p21 mRNA and protein by MCGA3 as a major factor in the enhancement of UVA-induced apoptosis. p21 silencing, clearly demonstrated that p21 upregulation by MCGA3 plays a pivotal role in the enhancement of UVA-mediated apoptosis (Figure 6 ) as well as inhibition of cell proliferation by arresting the cell cycle at G 1 -S phase ( Figure 5 ). These finding is critical in understanding the proapoptotic mechanism of ROS-scavenging compound, MCGA3, in contrary to previous studies which show that UVA-mediated apoptosis is driven by ROS generation (de Gruijl, 2002; Agar et al., 2004) . Although it is well known that accelerated ROS leads to p53-dependent transcriptional activation of p21 (Gartel et al., 2001; Catalano et al., 2005) , HaCaT cells harbor mutations in p53 gene, rendering transcriptionally defective protein, thereby avoiding regulation of its downstream targets such as p21 and Bax. Therefore, we initially hypothesized that the ROSscavenging and iron-chelating potential of MCGA3 may play a role in the p21 induction by providing a hypoxic condition. Recent studies (Carmeliet et al., 1998; Abeysinghe et al., 2001; Goda et al., 2003) have shown that HIF-1a-involved p21 transcriptional activation without p53 transcriptional function. Our p21-promoter assays clearly reflect the p53-independent, Sp1-dependent transcriptional activation of p21 by MCGA3.
It has been shown that the iron chelating and hypoxia-mimic DFO resulted in the rapid accumulation of HIF-1a along with stabilization of p53 (Fukuchi et al., 1995) , supporting the notion that iron depletion or hypoxia prevents hydroxylation of proline-564 to stabilize the HIF-1a that subsequently leads to increased p53 levels by direct interaction (Hammond and Giaccia, 2005) . Thus, it is convincing to elucidate that iron chelation or hypoxia by MCGA3 leads to both increased levels of p53 ( Figure 7a ) and HIF-1a (Figure 9a ) and plays a critical role in Sp1-dependent transcriptional activation of p21. However, we excluded p53 involvement in the p21 activation in HaCaT cells due to transcriptionally inactive form of p53 in this cell line. This is consistent with and supported by previous observation that hypoxiainduced p53 also has a nonessential role in facilitating hypoxic activation of p21 promoter (Goda et al., 2003; Hammond and Giaccia, 2005) . MCGA3 treatment-resultant decrease in c-Myc, which is known to MCGA3 activates p21 and enhances UVA-mediated apoptosis M-H Kweon et al repress Sp1-dependent p21 transcription and to be inhibited by iron chelation (Fan et al., 2001) , raised an interesting question whether c-Myc downregulation contributes to p21 activation. However, silencing of c-Myc did not change HIF-1a and p21 protein level (Figure 9d ). These data suggest, in HaCaT cells, c-Myc alone is not sufficient to regulate p21 expression and activation of HIF-1a, at least, is required for MCGA3-mediated p21 regulation. Thus, we suggest a possibility that the Sp1-mediated transcriptional activation of p21 by MCGA3 is probably driven by its iron chelation and hypoxia-associated regulation of HIF-1a via both by c-Myc-dependent or -independent pathway (Figure 10) .
Inhibition of prosurvival pathways and enhancement of UVA-induced apoptosis by MCGA3 may provide significant insights for the development of chemopreventive strategies for skin cancer. However, further investigation is warranted for a better understanding of divergent roles of c-Myc and HIF-1a in Sp1-dependent p21 transcriptional activation by MCGA3 and its proapoptotic action against UVA.
Materials and methods
Chemicals
MCGA3 was purified from ethanol extracts of the bamboo leaves according to the published procedures (Kweon et al., 2001) . Stock solutions of MCGA3 (20 mM) were prepared in ethanol and stored at À801C until used. N-acetylcysteine (NAC), desferrioxamine (DFO) and FeCl 3 were purchased from Sigma, St Louis, MO, USA.
Cell culture and treatment
HaCaT cells were maintained in a monolayer culture for treatment of MCGA3 (2.5-50 mM) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics at standard cell culture conditions. After 24 h treatment of MCGA3, the cells were washed with phosphate-buffered saline (PBS) and irradiated with UVA be entered in J/cm 2 for UVA and mJ/cm 2 for UVB; variations in energy output are automatically compensated.
Annexin-V-FLUOS and PI staining
Confluent HaCaT cells grown on covered chamber slides were pretreated with MCGA3 for 24 h followed by UVA irradiation. At 12 h post UVA irradiation, the apoptotic cells were detected by using Annexin-V-FLUOS apoptosis detection kit (Roche Applied Science, Indianapolis, IN, USA) according to manufacturer's instruction. In this assay, the viable cells were unstained, cells in the early stages of apoptosis were stained with annexin (green fluorescence) but not with PI (red fluorescence), and cells undergoing late stages of apoptosis were stained both with annexin and PI.
Immunoblot analysis
Western blotting was performed as described previously (Kweon et al., 2006) . Primary antibodies against HIF-1a, ferrtinH, TfR1, p53, GADD, PCNA and p27 (dilution 1:200, Santa Cruz Biotechnology, Santa Cruz, CA, USA); p-PKCa Ser657, total PKCa, p-AKTSer473, Bax, Bak and PI3Kp85 (dilution 1:1000-2000, Upstate, Charlottesville, VA, USA); p21, cyclin D1, Bcl-xL, Caspase-3, Caspase-8, PKCa, PARP, p-ERK44/42, p-p38, p-SAPK/JNK, p42MAPK and total ERK1/2 (dilution 1:1000-2000, Cell signaling) and c-Myc (dilution 1:2000, BD Pharmingen, San Jose, CA, USA) were used to detect their corresponding antigens.
Promoter-reporter assay
The human p21 promoter constructs pGL3 (À2325/ þ 8 hpluc), pGL3 (À215/ þ 8 hp-luc) and pGL3 (À2325/ þ 8 D-143/ þ 8 hp-luc) plasmids were generously provided from Dr Kimitris Kardassis (University of Crete Medical School, Herakleion, Greece) and have been described previously (Koutsodontis et al., 2002) . Briefly HaCaT cells were plated in 24-well plates at a density of 5 Â 10 4 cells/well and transfected with 200 ng of indicated p21 constructs along with 20 ng of Renilla luciferase plasmid as a transfection control. After 24 h of transfection, cells were washed with PBS and treated with MCGA3 (10 mM) for additional 24 h (for timecourse assay, 30 mM MCGA3 was treated for additional 2-24 h) or MCGA3 along with DFO, FeCl 3 or NAC for 24 h in complete medium. The cells were lysed with passive lysis buffer and Relative Luciferase Activity (RLA) was measured using DualLuciferase reporter assay system (Promega, Madison, WI, USA).
RNA interference
To silence the p21 and c-Myc in HaCaT cells, cells grown in six-well plates or in covered culture slides were transfected with 25-100 nmol/l of siRNAs (Cell signalling, Beverly, MA, USA) or with same amount of control siRNA (Dharmacon, Lafayette, CO, USA) using Lipofectamine 2000 transfection kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After 6-24 h of transfection, cells were harvested for protein lysate or for subsequent treatment with MCGA3 followed by UVA irradiation to perform Ki67 immunocytochemistry, cell cycle analysis and flow cytometry.
Flow cytometry
Flow cytometry for apoptosis analysis was performed as described (Kweon et al., 2004) . Briefly, cells grown in six-well culture plates were transfected with p21-siRNA (25 nM; 12 h) followed by treatment with MCGA3 and UVA. After 24 h, cells were trypsinized and processed for labeling with fluorescein-tagged dUTP nucleotide and PI using Apo-Direct apoptosis kit (Phoenix Flow Systems, San Diego, CA, USA), and were analysed by flow cytometry. MCGA3 activates p21 and enhances UVA-mediated apoptosis M-H Kweon et al treated with DCFH-DA (20 mM) for 60 min, and then incubated with 0.5 mM MitoTracker deep red 633 (Molecular Probes, Eugene, OR, USA) for 15 min before microscopy.
Immunofluorescence and confocal microscopy
Immunocytochemistry
Cells transfected with p21-siRNA (25 nM) or control siRNA (25 nM) for 12 h on culture slides were treated with or without MCGA3 (10 mM; 24 h) followed by UVA (30 J/cm 2 ) irradiation. At 1 h post-irradiation, the cells were fixed using cold methanol (À201C) for 10 min and incubated with monoclonal rabbit anti-Ki67 antibody (2.5 mg/ml) or monoclonal mouse anti-p21 in PBS containing 1.5% goat serum albumin overnight at 41C followed by incubation with secondary anti-rabbit immunoglobulin G (IgG) antibody horseradish peroxidase (HRP) conjugate. Immunoreaction was visualized with 3,3 0 -diamino-benzidine (DAB) as substrate and counter-stained with hematoxylin.
Reverse transcription-polymerase chain reaction Total RNA was extracted from the indicated cells using RNeasy kit (Qiagen, Valencia, CA, USA). Total RNA (0.5-1 mg) was subjected to RT-PCR using one-step RT-PCR premix kit (Promega) and primers for human p21 (sense 5 0 -ACC CTC TCT ATG CTC AAG GT-3 0 , antisense 5 0 -CCT TGT TCC GCT GCT AAT CA, PCR product size -375 bp).
